LTRN
LTRN
NASDAQ · Biotechnology

Lantern Pharma Inc

$2.64
+0.08 (+3.13%)
As of Feb 8, 2:22 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.75M 4.21M 3.91M
Net Income 909.1K 778.9K 578.2K
EPS
Profit Margin 19.1% 18.5% 14.8%
Rev Growth +21.8% +17.5% +9.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 4.41M 4.81M 3.82M
Total Equity 18.08M 16.17M 15.43M
D/E Ratio 0.24 0.30 0.25
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.38M 1.12M 1.11M
Free Cash Flow 932.9K 1.05M 869.6K